Walgreens Boots Alliance Q2 2025: sales up 4.1 percent but EPS plummets

THE WHAT? Walgreens Boots Alliance has announced its results for the second quarter of fiscal 2025. The drug store conglomerate said that sales increased 4.1 percent year-on-year to US$38.6 billion and loss per share narrowed to US$3.30 compared to US$6.85 in the year-ago quarter.

THE DETAILS However, adjusted EPS was US$0.63 compared to US$1.20 in the same period last year, which WBA attributed to the prior year adjusted effective tax benefit, lower retail sales and prior-year sale leaseback gains.

The company is withdrawing fiscal 2025 guidance in light of the fact it is to be acquired by entities affiliated with Sycamore Partners.

THE WHY? Chief Executive Officer Tim Wentworth, reveals, “Second quarter results reflect disciplined cost management and improvement in US Healthcare, which were partially offset by weaker front-end results in US Retail Pharmacy, while significant legal settlements resulted in continued negative free cash flow. We remain in the early stages of our turnaround plan, and continue to expect that meaningful value creation will take time, enhanced focus and balancing future cash needs with necessary investments to navigate a changing pharmacy and retail landscape.”

The post Walgreens Boots Alliance Q2 2025: sales up 4.1 percent but EPS plummets appeared first on Global Cosmetics News.